sweroside

10/01/2021 - "In previous studies, sweroside has been reported to have anti-inflammatory effect on LPS-induced inflammation by alleviating NF-κB signaling pathway. "
10/01/2021 - "In conclusion, sweroside can protect LPS-induced ALI mice through inhibiting inflammation."
04/01/2019 - "Protective Effects of Sweroside on IL-1β-Induced Inflammation in Rat Articular Chondrocytes Through Suppression of NF-κB and mTORC1 Signaling Pathway."
11/01/2023 - "Herein, we established a renal injury model in vitro by inducing human renal tubular epithelial cell (HK-2 cells) injury by HG. Then, the effects of sweroside on HK-2 cell activity, inflammation, reactive oxygen species (ROS) production, and epithelial mesenchymal transition (EMT) were observed. "
03/01/2019 - "Sweroside could alleviate the inflammation by inhibiting cell proliferation through arresting the cell cycle at the G0/G1 phase, by suppressing pro-inflammatory cytokines and by promoting anti-inflammatory cytokines in LPS-induced RAW264.7 cells. "

11/01/2017 - "Sweroside eradicated leukemia cells and attenuated pathogenic processes in mice by inducing apoptosis."
11/01/2017 - "Our study highlighted the therapeutic potential of sweroside, and provided new insights into the molecular mechanism of sweroside chemosensitization in human leukemia."
11/01/2017 - "Here, our study showed the potential of sweroside as an effective agent against human leukemia using in vitro and in vivo approaches. "
11/01/2017 - "Sweroside treatment obviously reduced the cell viability in human leukemia cell lines and primary human leukemia cells. "

01/01/2018 - "We screened six components from V. baillonii, among which, sweroside exhibited the strongest protective effects on aconitine-induced cardiac toxicity. "
01/01/2018 - "Sweroside Alleviated Aconitine-Induced Cardiac Toxicity in H9c2 Cardiomyoblast Cell Line."

06/12/2020 - "Sweroside ameliorates NAFLD in high-fat diet induced obese mice through the regulation of lipid metabolism and inflammatory response."
06/12/2020 - "Biochemical and pathological analysis were conducted to investigate the effect of sweroside on NAFLD. "

01/01/2021 - "Overall, the results indicated that sweroside pretreatment dose-dependently led to a significant enhancement in cell viability, a decrease in release of CK-MB and LDH, a reduction in infarct size, and an improvement in cardiac function. "